News on Robert Kohlhammer GmbH from BioPortfolio.com http://www.BioPortfolio.com Consolidated Robert Kohlhammer GmbH news from BioPortfolio.com Wed, 10 Feb 2010 13:59:04 GMT en Mycobacteria: Findings in mycobacteria reported from Schulke & Mayr GmbHhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4041193&HITNO=0&MSIZE=380&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Robert%20Kohlhammer%20GmbH&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4041193&THISHREF=http://c.moreover.com/click/here.pl%3fz2539026555%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4041193&HITNO=0&MSIZE=380&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Robert%20Kohlhammer%20GmbH&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4041193&THISHREF=http://c.moreover.com/click/here.pl%3fz2539026555%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comNewsRX: Kamada Announces Enrollment Of First Patient In Its Pivotal Study For Inhaled AAT In Europehttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4039685&HITNO=1&MSIZE=380&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Robert%20Kohlhammer%20GmbH&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4039685&THISHREF=http://c.moreover.com/click/here.pl%3fz2538321789%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4039685&HITNO=1&MSIZE=380&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Robert%20Kohlhammer%20GmbH&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4039685&THISHREF=http://c.moreover.com/click/here.pl%3fz2538321789%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comMedical News Today: Research and Markets: Ribonucleic Acid (RNA) Therapeutics - Strong Potential to Address Unmet Needs in Pharmahttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4042214&HITNO=2&MSIZE=380&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Robert%20Kohlhammer%20GmbH&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4042214&THISHREF=http://c.moreover.com/click/here.pl%3fz2539361221%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4042214&HITNO=2&MSIZE=380&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Robert%20Kohlhammer%20GmbH&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4042214&THISHREF=http://c.moreover.com/click/here.pl%3fz2539361221%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comBusiness Wire: Research and Markets: Ribonucleic Acid (RNA) Therapeutics - Strong Potential to Address Unmet Needs in Pharmahttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4042212&HITNO=3&MSIZE=380&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Robert%20Kohlhammer%20GmbH&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4042212&THISHREF=http://c.moreover.com/click/here.pl%3fz2539361205%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4042212&HITNO=3&MSIZE=380&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Robert%20Kohlhammer%20GmbH&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4042212&THISHREF=http://c.moreover.com/click/here.pl%3fz2539361205%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comBusiness Wire UK: Boehringer Ingelheim to make Japanese drug maker SSP 100% subsidiaryhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4041413&HITNO=4&MSIZE=380&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Robert%20Kohlhammer%20GmbH&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4041413&THISHREF=http://c.moreover.com/click/here.pl%3fz2539099311%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4041413&HITNO=4&MSIZE=380&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Robert%20Kohlhammer%20GmbH&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4041413&THISHREF=http://c.moreover.com/click/here.pl%3fz2539099311%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comKyodo: Daiichi Sankyo's subsidiary seeks approval for Alzheimer's type Dementia treatment in Japanhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4039734&HITNO=5&MSIZE=380&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Robert%20Kohlhammer%20GmbH&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4039734&THISHREF=http://c.moreover.com/click/here.pl%3fz2538348937%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4039734&HITNO=5&MSIZE=380&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Robert%20Kohlhammer%20GmbH&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4039734&THISHREF=http://c.moreover.com/click/here.pl%3fz2538348937%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comTherapeutics Daily: SuppreMol appoints Dr. Robert Phelps as Head of Business Development & Licensinghttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4033095&HITNO=6&MSIZE=380&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Robert%20Kohlhammer%20GmbH&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4033095&THISHREF=http://c.moreover.com/click/here.pl%3fz2535006984%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4033095&HITNO=6&MSIZE=380&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Robert%20Kohlhammer%20GmbH&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4033095&THISHREF=http://c.moreover.com/click/here.pl%3fz2535006984%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharma Live: ALIUD Pharma GmbH-Company Report - new market report releasedhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4037799&HITNO=7&MSIZE=380&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Robert%20Kohlhammer%20GmbH&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4037799&THISHREF=http://c.moreover.com/click/here.pl%3fz2537289098%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4037799&HITNO=7&MSIZE=380&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Robert%20Kohlhammer%20GmbH&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4037799&THISHREF=http://c.moreover.com/click/here.pl%3fz2537289098%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPR inside: Kamada Announces Enrollment of First Patient in Its Pivotal Study for Inhaled AAT in Europehttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4037052&HITNO=8&MSIZE=380&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Robert%20Kohlhammer%20GmbH&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4037052&THISHREF=http://c.moreover.com/click/here.pl%3fz2536879771%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4037052&HITNO=8&MSIZE=380&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Robert%20Kohlhammer%20GmbH&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4037052&THISHREF=http://c.moreover.com/click/here.pl%3fz2536879771%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPipelineReview: Hepatitis C Virus: Research in the area of hepatitis C virus reported from Boehringer Ingelheim GmbH, Department of Biological Scienceshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4033358&HITNO=9&MSIZE=380&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Robert%20Kohlhammer%20GmbH&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4033358&THISHREF=http://c.moreover.com/click/here.pl%3fz2535162672%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4033358&HITNO=9&MSIZE=380&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Robert%20Kohlhammer%20GmbH&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4033358&THISHREF=http://c.moreover.com/click/here.pl%3fz2535162672%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comNewsRX: Antisense Pharma GmbH-Company Report - new market report releasedhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4037053&HITNO=10&MSIZE=380&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Robert%20Kohlhammer%20GmbH&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4037053&THISHREF=http://c.moreover.com/click/here.pl%3fz2536880950%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4037053&HITNO=10&MSIZE=380&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Robert%20Kohlhammer%20GmbH&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4037053&THISHREF=http://c.moreover.com/click/here.pl%3fz2536880950%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPR inside: Sorbus Pharmaceuticals GmbH incorporated in Vienna, Austriahttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4034982&HITNO=11&MSIZE=380&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Robert%20Kohlhammer%20GmbH&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4034982&THISHREF=http://c.moreover.com/click/here.pl%3fz2536073592%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4034982&HITNO=11&MSIZE=380&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Robert%20Kohlhammer%20GmbH&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4034982&THISHREF=http://c.moreover.com/click/here.pl%3fz2536073592%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comBionity.com: CellAct Pharma GmbH-Company Report - new market report releasedhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4033999&HITNO=12&MSIZE=380&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Robert%20Kohlhammer%20GmbH&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4033999&THISHREF=http://c.moreover.com/click/here.pl%3fz2535548161%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4033999&HITNO=12&MSIZE=380&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Robert%20Kohlhammer%20GmbH&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4033999&THISHREF=http://c.moreover.com/click/here.pl%3fz2535548161%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPR inside: Karl Kolb GmbH & CO. KG and ELWE Technik GmbH Join Forceshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4032846&HITNO=13&MSIZE=380&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Robert%20Kohlhammer%20GmbH&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4032846&THISHREF=http://c.moreover.com/click/here.pl%3fz2534833530%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4032846&HITNO=13&MSIZE=380&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Robert%20Kohlhammer%20GmbH&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4032846&THISHREF=http://c.moreover.com/click/here.pl%3fz2534833530%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comChemie.de: QIAGEN broadens molecular diagnostic reach with ESE GmbH acquisitionhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4032825&HITNO=14&MSIZE=380&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Robert%20Kohlhammer%20GmbH&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4032825&THISHREF=http://c.moreover.com/click/here.pl%3fz2534827357%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4032825&HITNO=14&MSIZE=380&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Robert%20Kohlhammer%20GmbH&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4032825&THISHREF=http://c.moreover.com/click/here.pl%3fz2534827357%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comDrug Discovery News: